Showing results (931-940 of 1,007) with videos related to

Sort By:
Pageof 101
BMJ Open|November 15, 2017
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour typesCaroline Lonez, Bikash Verma, Alain Hendlisz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabineJavier Cortes, Linda Vahdat, Joanne L Blum, et al.
Blood Cancer Journal|May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell TherapyDanai Dima, Al-Ola Abdallah, James A Davis, et al.
Blood Neoplasia|November 24, 2025
Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning modelsAhmet Celal Toprak, Mutlu Mete, Julia J Shi, et al.
The Journal of Rheumatology|June 17, 2016
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing SpondylitisMilla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2020
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial HypertensionGéraldine Vitry, Roxane Paulin, Yann Grobs, et al.
International Journal of Molecular Sciences|April 3, 2021
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic ApproachKarima Habbout, Junichi Omura, Charifa Awada, et al.
Targeted Oncology|November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid TumorsJean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.
Journal for Immunotherapy of Cancer|May 24, 2025
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trialJérémy Blanc, Aurélien Carnot, Philippe Barthélémy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industryR Bartsch, S Frings, M Marty, et al.
Pageof 101